RY 174.39 2.4016% SHOP 149.115 2.5974% TD-PFM 24.63 -0.0811% TD-PFL 24.7 0.2028% TD 78.325 0.1214% ENB 60.6 1.3039% BN 80.4 1.9787% TRI 226.27 0.7525% CNQ 48.285 2.2771% CP 104.53 1.6038% CNR 151.74 1.5459% BMO 132.69 0.9203% BNS 78.845 0.1715% CSU 4600.2002 2.157% CM 91.15 0.474% MFC 45.79 1.6878% ATD 78.38 1.5285% NGT 60.14 0.0499% TRP 70.15 1.977% SU 57.44 0.5954%
Last update at 2024-11-21T20:57:00Z
Big Tobacco proposes nearly $24 billion payment to settle Canada lawsuits
Fri 18 Oct 24, 08:42 AMJT Group Completes Acquisition of Vector Group Ltd.
Mon 07 Oct 24, 01:00 PMJT Group to Acquire Vector Group Ltd.
Wed 21 Aug 24, 10:32 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 593450.00M | 472390.00M | 420063.00M | 465232.00M | 531486.00M |
| Minority interest | -1458.00000M | -1691.00000M | 76660.00M | 80916.00M | 69851.00M |
| Net income | 442716.00M | 338490.00M | 310254.00M | 348190.00M | 385676.00M |
| Selling general administrative | 941538.00M | 888574.00M | 784472.00M | 831707.00M | 770407.00M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 1566843.00M | 1367977.00M | 1194560.00M | 1233327.00M | 1282928.00M |
| Reconciled depreciation | 199651.00M | 187057.00M | 179654.00M | 183852.00M | 158671.00M |
| Ebit | 653575.00M | 499021.00M | 469054.00M | 502355.00M | 570738.00M |
| Ebitda | 884373.00M | 705092.00M | 661061.00M | 694610.00M | 729409.00M |
| Depreciation and amortization | 230798.00M | 206071.00M | 192007.00M | 192255.00M | 158671.00M |
| Non operating income net other | - | - | - | 0.00000M | 0.00000M |
| Operating income | 653575.00M | 499021.00M | 469054.00M | 502355.00M | 564984.00M |
| Other operating expenses | 2012265.00M | 1829813.00M | 1627549.00M | 1678281.00M | 1654909.00M |
| Interest expense | 91272.00M | 45645.00M | 61344.00M | 45526.00M | 39252.00M |
| Tax provision | 149277.00M | 132208.00M | 108034.00M | 103609.00M | 144055.00M |
| Interest income | 31147.00M | 19013.00M | 12353.00M | 8402.00M | 5754.00M |
| Net interest income | -60125.00000M | -26632.00000M | -48991.00000M | -37124.00000M | -33498.00000M |
| Extraordinary items | - | - | - | 0.00000M | 0.00000M |
| Non recurring | - | - | - | 0.00000M | 0.00000M |
| Other items | - | - | - | 0.00000M | 0.00000M |
| Income tax expense | 149277.00M | 132208.00M | 108034.00M | 103609.00M | 144055.00M |
| Total revenue | 2657832.00M | 2324838.00M | 2092561.00M | 2175626.00M | 2215962.00M |
| Total operating expenses | 921276.00M | 872952.00M | 729548.00M | 735982.00M | 721875.00M |
| Cost of revenue | 1090989.00M | 956861.00M | 898001.00M | 942299.00M | 933034.00M |
| Total other income expense net | -60125.00000M | -26631.00000M | -48991.00000M | -37123.00000M | -33498.00000M |
| Discontinued operations | - | - | - | 0.00000M | 0.00000M |
| Net income from continuing ops | 444173.00M | 340182.00M | 312029.00M | 361623.00M | 387431.00M |
| Net income applicable to common shares | 442716.00M | 338490.00M | 310253.00M | 348190.00M | 385677.00M |
| Preferred stock and other adjustments | - | - | - | 0.00000M | 0.00000M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 6548078.00M | 5774209.00M | 5381382.00M | 5553071.00M | 5461400.00M |
| Intangible assets | 246442.00M | 307152.00M | 363604.00M | 440434.00M | 503076.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 649182.00M | 562035.00M | 493993.00M | 410443.00M | 385871.00M |
| Total liab | 2931317.00M | 2888128.00M | 2781888.00M | 2809459.00M | 2760955.00M |
| Total stockholder equity | 3540435.00M | 2809258.00M | 2522834.00M | 2662696.00M | 2630594.00M |
| Deferred long term liab | - | - | - | 0.00000M | 0.00000M |
| Other current liab | 885267.00M | 717654.00M | 652314.00M | 701050.00M | 716190.00M |
| Common stock | 100000.00M | 100000.00M | 100000.00M | 100000.00M | 100000.00M |
| Capital stock | 100000.00M | 100000.00M | 100000.00M | 100000.00M | 100000.00M |
| Retained earnings | 3089909.00M | 2863843.00M | 2783718.00M | 2750506.00M | 2660381.00M |
| Other liab | 547679.00M | 612081.00M | 591406.00M | 577753.00M | 603456.00M |
| Good will | 2446063.00M | 2060965.00M | 1909392.00M | 2002595.00M | 2008416.00M |
| Other assets | 91429.00M | 120419.00M | -1.00000M | 1.00M | 1.00M |
| Cash | 866885.00M | 721731.00M | 538844.00M | 357158.00M | 282063.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 1562664.00M | 1500326.00M | 1323793.00M | 1501757.00M | 1430185.00M |
| Current deferred revenue | - | 83994.00M | 93470.00M | 107975.00M | 83013.00M |
| Net debt | 91426.00M | 196891.00M | 420037.00M | 617344.00M | 695717.00M |
| Short term debt | 137308.00M | 142901.00M | 141469.00M | 284135.00M | 250466.00M |
| Short long term debt | 137308.00M | 142901.00M | 141469.00M | 284135.00M | 250466.00M |
| Short long term debt total | 958311.00M | 918622.00M | 958881.00M | 974502.00M | 977780.00M |
| Other stockholder equity | 350526.00M | -154585.00000M | -360884.00000M | -187810.00000M | -129787.00000M |
| Property plant equipment | 775957.00M | 755843.00M | 759290.00M | 803239.00M | 758841.00M |
| Total current assets | 2723591.00M | 2321289.00M | 2003919.00M | 1925673.00M | 1809406.00M |
| Long term investments | - | - | - | 0.00000M | 0.00000M |
| Net tangible assets | 847930.00M | 441141.00M | 249838.00M | 219667.00M | 119102.00M |
| Short term investments | 37677.00M | 17254.00M | 18828.00M | 21943.00M | 35633.00M |
| Net receivables | 477941.00M | 457087.00M | 412492.00M | 458543.00M | 456601.00M |
| Long term debt | 821003.00M | 775721.00M | 817412.00M | 690367.00M | 727314.00M |
| Inventory | 691906.00M | 563182.00M | 539762.00M | 677586.00M | 649238.00M |
| Accounts payable | 540089.00M | 555777.00M | 436540.00M | 408597.00M | 380516.00M |
| Total permanent equity | - | - | - | 0.00000M | 0.00000M |
| Noncontrolling interest in consolidated entity | - | - | - | 0.00000M | 0.00000M |
| Temporary equity redeemable noncontrolling interests | - | - | - | 0.00000M | 0.00000M |
| Accumulated other comprehensive income | - | - | - | 0.00000M | 0.00000M |
| Additional paid in capital | - | - | - | 0.00000M | 0.00000M |
| Common stock total equity | - | - | - | 0.00000M | 0.00000M |
| Preferred stock total equity | - | - | - | 0.00000M | 0.00000M |
| Retained earnings total equity | - | - | - | 0.00000M | 0.00000M |
| Treasury stock | - | - | - | 0.00000M | 0.00000M |
| Accumulated amortization | - | - | - | 0.00000M | 0.00000M |
| Non currrent assets other | 104963.00M | 75416.00M | 94099.00M | 105905.00M | 110331.00M |
| Deferred long term asset charges | - | - | - | 0.00000M | 0.00000M |
| Non current assets total | 3824487.00M | 3452920.00M | 3377464.00M | 3627397.00M | 3651993.00M |
| Capital lease obligations | - | - | - | 0.00000M | 0.00000M |
| Long term debt total | - | - | - | 0.00000M | 0.00000M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -101822.00000M | -3878.00000M | 27067.00M | 31990.00M | -26612.00000M |
| Change to liabilities | -24723.00000M | 141223.00M | 39288.00M | 28294.00M | 37764.00M |
| Total cashflows from investing activities | -101822.00000M | -97499.00000M | 5354.00M | -123571.00000M | -383307.00000M |
| Net borrowings | -29762.00000M | -78837.00000M | -19849.00000M | -11403.00000M | 210006.00M |
| Total cash from financing activities | -306176.00000M | -353138.00000M | -297404.00000M | -333832.00000M | -62360.00000M |
| Change to operating activities | -39589.00000M | -64419.00000M | 5072.00M | -4912.00000M | -36557.00000M |
| Net income | 593450.00M | 472390.00M | 420063.00M | 465232.00M | 531486.00M |
| Change in cash | 145154.00M | 182887.00M | 181686.00M | 75095.00M | -3423.00000M |
| Begin period cash flow | 721731.00M | 538844.00M | 357158.00M | 282063.00M | 285486.00M |
| End period cash flow | 866885.00M | 721731.00M | 538844.00M | 357158.00M | 282063.00M |
| Total cash from operating activities | 483799.00M | 598909.00M | 519833.00M | 540410.00M | 461389.00M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 199651.00M | 187057.00M | 179654.00M | 183852.00M | 158671.00M |
| Other cashflows from investing activities | 12514.00M | 6735.00M | 1784.00M | 2073.00M | 49747.00M |
| Dividends paid | 266175.00M | 251935.00M | 273134.00M | 270871.00M | 259671.00M |
| Change to inventory | -93910.00000M | 9770.00M | 748.00M | -32817.00000M | -53058.00000M |
| Change to account receivables | 26574.00M | -29891.00000M | 21554.00M | 10673.00M | -30818.00000M |
| Sale purchase of stock | -1.00000M | -1.00000M | -1.00000M | -50001.00000M | 0.00000M |
| Other cashflows from financing activities | 32849.00M | 42.00M | -3016.00000M | 356.00M | 387956.00M |
| Change to netincome | -177654.00000M | -117221.00000M | -56403.00000M | -32419.00000M | -146099.00000M |
| Capital expenditures | 99408.00M | 102918.00M | 108620.00M | 133370.00M | 158810.00M |
| Change receivables | - | - | - | 0.00000M | 0.00000M |
| Cash flows other operating | - | - | - | 0.00000M | 0.00000M |
| Exchange rate changes | - | - | - | 0.00000M | 0.00000M |
| Cash and cash equivalents changes | - | - | - | 0.00000M | 0.00000M |
| Change in working capital | -103040.00000M | 56683.00M | 66662.00M | 25009.00M | -82669.00000M |
| Stock based compensation | - | - | - | - | - |
| Other non cash items | -206262.00000M | -117221.00000M | -146546.00000M | -133683.00000M | -146099.00000M |
| Free cash flow | 384391.00M | 495991.00M | 411213.00M | 407040.00M | 302579.00M |
Sector: Consumer Defensive Industry: Tobacco
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| JAPAY Japan Tobacco ADR |
0.14 1.04% | 13.54 | 13.91 | 14.62 | 0.02 | 1.68 | 0.02 | 0.05 |
| PM Philip Morris International Inc |
0.81 0.62% | 131.20 | 18.05 | 14.08 | 4.17 | - | 5.47 | 13.66 |
| MO Altria Group |
0.05 0.09% | 56.03 | 8.24 | 8.09 | 3.47 | 27.30 | 4.61 | 7.77 |
| BTI British American Tobacco p.l.c. |
0.01 0.03% | 36.98 | 5.94 | 6.23 | 2.34 | 0.72 | 4.07 | 7.90 |
| BTAFF British American Tobacco p.l.c |
- -% | 36.02 | 5.97 | 6.28 | 2.36 | 0.72 | 4.07 | 7.90 |
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company also provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products, such as frozen udon noodles, packed rice, and frozen okonomiyaki; bakery products; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was incorporated in 1985 and is headquartered in Tokyo, Japan.
1-1, Toranomon 4-chome, Tokyo, Japan, 105-6927
| Name | Title | Year Born |
|---|---|---|
| Mr. Masamichi Terabatake | Pres, CEO, Pres of Tobacco Bus. & Representative Director | 1965 |
| Mr. Kazuhito Yamashita | Sr. VP of Corp. Governance & Compliance and Director | 1963 |
| Mr. Naohiro Minami | Exec. VP of Fin. & Corp. Communications and Representative Director | 1964 |
| Mr. Kiyohide Hirowatari | EVP of CS, Sustainability, People, Culture, IT, Legal, OR, BA, Pharma & Food Bus. and Rep. Director | 1965 |
| Mr. Mutsuo Iwai | Exec. Chairman | 1960 |
| Nobuya Kato | Sr. VP & CFO | NA |
| Dinesh Babu Thotakura | Gen. Mang. of Media & Investor Relations Division | NA |
| Osamu Hirose | Sr. VP & Gen. Counsel | NA |
| Mr. Junichi Fukuchi | SVP, CEO of Japanese Tobacco Bus. - Tobacco Bus. Planning - Tobacco Bus. | NA |
| Mr. Muneaki Fujimoto | Sr. VP & Pres of Pharmaceutical Bus. | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...